Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance?

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICI) have failed to overcome the high therapy resistance of Metastatic Uveal Melanoma (MUM) in contrast to the dramatic benefits of immunotherapy seen in many other tumor entities. Considering the poor clinical outcome and survival rates of MUM, the urge...

Descripción completa

Detalles Bibliográficos
Autores principales: Blomen, Chiara L., Kött, Julian, Hartung, Tabea I., Torster, Leopold K., Gebhardt, Christoffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699813/
https://www.ncbi.nlm.nih.gov/pubmed/34945010
http://dx.doi.org/10.3390/cancers13246390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699813/
https://www.ncbi.nlm.nih.gov/pubmed/34945010
http://dx.doi.org/10.3390/cancers13246390

Ejemplares similares